Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | GFER | P55789 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7402692 | 0.81 | MAPK1 (0.55) | MAPK1MAPTALDH1A1LMNAGFER | |
| SCHEMBL7399845 | 0.79 | DRD2 (0.64) | HSD17B10 | |
| Hydrochloric Acid SCHEMBL7403139 | 0.78 | DRD2 (0.62) | HSD17B10 | |
| SCHEMBL7404596 | 0.78 | DRD2 (0.59) | MAPK1MAPTALDH1A1LMNAGFER | |
| SCHEMBL7403392 | 0.75 | MAPK1 (0.56) | MAPK1MAPTALDH1A1LMNAGFER | |
| SCHEMBL7398361 | 0.75 | MAPK1 (0.56) | MAPK1MAPTALDH1A1LMNAGFER | |
| SCHEMBL7403037 | 0.74 | MAPT (0.48) | MAPK1MAPTALDH1A1LMNAGFER | |
| SCHEMBL7397186 | 0.74 | MAPK1 (0.54) | MAPK1MAPTALDH1A1LMNAGFER | |
| SCHEMBL12182367 | 0.72 | L3MBTL1 (0.68) | MAPK1MAPTALDH1A1LMNAGFER | |
| SCHEMBL20419342 | 0.72 | GFER (0.79) | MAPK1MAPTALDH1A1LMNAGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6133446-A | Heterocyclic compounds for the treatment of CNS and cardiovascular disorders | PHARMACIA & UPJOHN COMPANY (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0737189-B1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | UPJOHN CO (US) | 1999-07-28 | — | — | EP | disclosed |
| EP-0737189-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 1996-10-16 | — | — | EP | disclosed |
| WO-1995018118-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS | THE UPJOHN COMPANY (US) | 1995-07-06 | — | — | WO | disclosed |